Home Markets Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

Dec 21, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/lillys-weightloss-drug-zepbound-wins-us-fda-approval-for-sleep-apnea-3785420

You May Also Like

US says BYD, Baidu, Alibaba and other tech giants are aiding China’s military

WhiteHawk Minerals prices upsized IPO at $26 per share

OpenAI files for US IPO after Anthropic as AI giants head to public markets

Salesforce to acquire m3ter for consumption billing expansion

Intesa launches $35 billion Monte dei Paschi bid to redraw Italy’s financial map

AstraZeneca obesity pill shows 10.5% weight loss in trial